Our state-of-the-art proprietary eutectic formulation technology is a proven approach for significantly enhancing the bioavailability of even the most difficult to formulate APIs.

The quality of our formulations is matched by our development speed. We combine API modelling with high throughput development processes to build the optimum formulation(s) in the shortest time.

The only manufacturing operations at SeraNovo are gentle heating and stirring. This simple procedure allows for easy transfer and rapid upscaling of the clinical formulation.

Our formulations only consist of safe excipients. The right combination of safe excipients is essential, be it for enabling higher exposure during toxicology studies or for moving a product into the clinic.